Using Virtual Skin and Tissue Modeling to Accelerate Development of Novel Therapies and Devices

Drug Discovery and Development, Life Sciences, Medical Device, Medical Device Design, Medical Device Innovations, Pharmaceutical,
  • Monday, July 16, 2018

Modeling and simulation technologies have advanced to the point where they can accurately simulate skin and tissue response to both devices and fluids to accelerate innovation for biopharma and medical device products. This means saving money and resources by discovering and developing therapies and devices in silico before stepping foot inside the lab.

Join us for this live webinar where our expert speaker will discuss:

  • How virtual skin and tissue modeling can simulate needle penetration and fluid diffusion
  • Leading companies using modeling and simulation, combined with the latest in artificial intelligence and advanced visualization to transform their R&D
  • A holistic, model-based design environment driving technological efficiencies when transferring to manufacturing

Speaker

Sara Dutta, Ph.D., Business Consultant – Life Sciences Industry, Dassault Systèmes

Sara Dutta is a Business Consultant for the Life Sciences Industry at Dassault Systèmes. She is based at the US headquarters in Waltham, MA. Her aim is to leverage her expertise and the strength of the Dassault Systèmes platform to help pharmaceutical and medical device companies innovate and transform their businesses.

Prior to joining Dassault Systèmes, over the last 7 years, Sara specialized in computational modeling to investigate arrhythmia mechanisms and drug effects on the heart. She worked for 3 years as an ORISE research fellow at the Center for Drug Evaluation and Research (CDER) at the US Food and Drug Administration (FDA), where she led work on developing computational techniques to assess cardiac safety and efficacy for the Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative. As part of a wider collaborative effort, she worked closely with experts from the FDA, academia and industry.

Prior to working at the FDA, she completed her PhD in Professor Blanca Rodriguez’s multi-disciplinary research group, the Computational Cardiovascular Science Team, at the University of Oxford (UK). Sara is passionate about the strength of software and computational modeling to transform and enhance the life sciences industry, and eventually improve the patient’s life and experience.

Message Presenter

Who Should Attend?

Senior professionals from life sciences organizations, including:

  • Chief Operating Officers
  • Chief Scientific Officers

VPs/Directors/Managers of:

  • IT
  • Manufacturing
  • Operations
  • Quality Assurance (QA)
  • Quality Control (QC)
  • Regulatory Affairs
  • Research & Development
  • Process Development
  • Laboratory/Chemists

What You Will Learn

Join us for this live webinar where our expert speaker will discuss:

  • How virtual skin and tissue modeling can simulate needle penetration and fluid diffusion
  • Leading companies using modeling and simulation, combined with the latest in artificial intelligence and advanced visualization to transform their R&D
  • A holistic, model-based design environment driving technological efficiencies when transferring to manufacturing

Xtalks Partner

Dassault Systèmes

The pace of change in the Life Sciences industry is both exciting and extraordinary, resulting in core paradigm shifts in both strategies and processes for key industry stakeholders. Leading Life Sciences organizations understand that in order to meet these challenges they must excel in scientific leadership and innovation for processes throughout their ecosystem to create competitive advantage, and deliver holistic, superior patient and physician-centric experiences.

Related Webinars

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account